Aktuellt
SENASTE
SyntheticMR delivered sales growth of 14% in Q3, which was below our expectations. Opex was lower than we expected leading to EBIT of SEK 4.5m (SEB at SEK 7.2m). While the company's comment that it is on track to deliver on its goals for 2023, we expect mid single digit negative revisions to consensus 2023 sales on the report.
LÄS MER
